EUROGIN homepage       Friday, November 17, 2017
 

International Forum on HPV and Skin / Dermatovenereology

 


HPV is definitely involved in the origin and development of genitoanal cancer of both genders (cervical cancer, vulval cancer, vaginal cancer, anal cancer and penile cancer). HPV types from the betapapillomaviruses (betaPV) genus may play a role in cutaneous squamous cell carcinoma. Functional data support a potential role for betaPV as cocarcinogens with UV, but with mechanisms likely to differ fundamentally to those established in anogenital cancer. HPV-specific antiviral agents are not currently available, but therapeutic anti- HPV vaccines are in development and would be especially appropriate for those persons for whom we can predict a high risk of multiple squamous cell carcinoma. Cutaneous squamous cell carcinomas are an eminent clinical problem in the management of immunosuppressed organ transplant recipients.

The following program has been organized in cooperation with the EADV (European Academy of Dermatology and Venereology) HPV Task Force and SCOPE (Skin Care in Organ Transplant Patients)


Program Committee:
J.N. Bouwes Bavinck (The Netherlands), G. Gross (Germany), J. Hercogova (Czech Republic), H. Pfister (Germany), M. Skerlev (Croatia)

The following sessions are of special interest to dermato-venereologists:


Sunday, July 8


TRAINING COURSE

A training course on fundamentals on HPV infection and cancer runs from 8.30 to 17.30. This course deals with all fundamentals of HPV infection and related diseases. A 90-minute section of the course (16.00 – 17.30) will focus on the following sites: anus, head&neck, skin

16.00 - 17.30 MTC2 - HPV infection & associated diseases in non-cervical sites: facts and figures Chair: Stina Syrjänen (Finland)
  • HPV genital infection and diseases in men
  A. Giuliano USA
  • Anal neoplasia: burden, epidemiology and prevention
  J. Palefsky USA
  • The HPV cause of head and neck cancers: epidemiology, burden and new developments
  M. Gillison USA
  • HPV associated diseases in the skin – current knowledge and perspectives
  H. Pfister Germany
  • Discussion
     


Monday, July 9


MAIN SCIENTIFIC SESSIONS

8.00 - 9.30 MSS1 - HPV associated diseases in non-genital human sites: new challenges
Chair: M. Gillison – K. Syrjänen
   
  • Keynote lecture: HPV-associated cancers – a growing problem?
  M. Stanley UK
  • (...)
     
  • The role of papillomavirus infection in skin cancer development
  J.N. Bouwes-Bavinck The Netherlands
  • HPV, oesophagus & lung: what evidence?
  K. Syrjänen Finland
  • The significance of HPV in the colon & rectum
  L. Lorenzon Italy
       
9.30 - 11.00 MSS2 - HPV vaccines – update and perspectives
Chair: J. Paavonen – M. Stanley
   



14.00 - 17.00

SEM 2- Seminar: HPV in dermatovenereology
Coordination : G. Gross, J. Hercegova, H. Pfister, M. Skerlev
     
  Part I      
  1. External genitalia and HPV associated diseases      
 
  • Epidemiology and burden of genital warts
  S. Garland Australia
 
  • Epidemiology and burden of VIN
  J. Bornstein Israel
 
  • Management
     
                  - Genital warts   G. Gross Germany
                  - VIN   M. Hampl Germany
 
  • Prevention
  A. Giuliano USA
  Part II      
 
  • Epidemiology of papillomavirus infections and skin cancer in organ transplant recipients
  J.N. Bouwes-Bavinck The Netherlands
 
  • Skin cancer in immunosuppressed patients
  J. Hercogova Czech Republic
 
  • Molecular mechanisms of keratinocyte transformation
  M. Tommasino France
 
  • Skin cancer development in beta-HPV transgenic mice
  H. Pfister Germany
 
  • HPV – skin deep and beyond
  M. Skerlev Croatia
 
  • Discussion – round table

     


Tuesday, July 10


MAIN SCIENTIFIC SESSION

8.00 - 10.00 Hot topics on HPV infection and diseases – exchanging points of view with the experts & public health representatives
Chair: E. Franco – J. Peto
   
  • (...)
     


EUROGIN CONSENSUS SESSSION ("Roadmap")

14.00 - 15.00 MSS7 - EUROGIN 2012 Roadmap
Chair: S. Franceschi – M. Gillison
   
  • Consensus meeting on HPV related cancers
     

This consensus conference will be organized between EUROGIN and the other scientific societies to establish a consensu on the impact of HPV infections on clinical practice related to cancers in the various relevant sites


SCIENTIFIC SESSION ON HPV AND SKIN CANCER

18.00 - 19.15 SS7: Non-cervical HPV associated diseases – current knowledge
Chair: J. Palefsky – C. Lacey
   
  • HPV, skin & sex
  M. Skerlev Croatia
  • Update on HPV-associated oral cancer in men
  A. Chaturvedi USA
  • New approaches to the treatment of AIN
  J. Palefsky USA
  • Penile HPV infection and disease in HIV-infected men
  C. Lacey UK
  • Female HPV data
  R. Crawford France
  • Economic burden of non-cervical human papillomavirus-related cancers in Western Europe: a scoping review
  N. Largeron France


Wednesday, July 11


8.30 - 12.00 Vulvar diseases course + accreditation
Coordinator:– J. Bornstein

The satellite course on vulvar disease has been designed for clinicians who currently treat or diagnose women with cervical and vaginal disease. The faculty will discuss current knowledge of vulvar benign and premalignant disease, from various aspects: pathophysiology, clinical features, histological appearance, and treatment. Common and difficult cases will be presented and discussed
  • Introduction
  J. Bornstein Israel
  • Benign HPV lesions: diagnosis and treatment
  M. Hampl Germany
  • Vulvar pain, etiology and diagnosis
  J. Bornstein Israel
  • VIN – diagnosis, terminology
  M. Sideri Italy
  • VIN – prevention and treatment
  E. Joura Austria
  • Vulvar carcinoma - current treatment
  M. Roy Canada
  • Vulvar pain: surgical and non-surgical treatments
  J. Bornstein Israel
  • Psycho-sexual aspects of vulvar disease
  M. Steben Canada
  • Summary and close